{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T13:16:48Z","timestamp":1782393408607,"version":"3.54.5"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:00:00Z","timestamp":1587945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:00:00Z","timestamp":1587945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1038\/s41401-020-0408-4","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T07:03:10Z","timestamp":1587970990000},"page":"1465-1475","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Diabetes downregulates peptide transporter 1 in the rat jejunum: possible involvement of cholate-induced FXR activation"],"prefix":"10.1038","volume":"41","author":[{"given":"Li-min","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-dong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,27]]},"reference":[{"key":"408_CR1","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.2042-7158.1997.tb06115.x","volume":"49","author":"I Tamai","year":"1997","unstructured":"Tamai I, Nakanishi T, Hayashi K, Terao T, Sai Y, Shiraga T, et al. The predominant contribution of oligopeptide transporter PepT1 to intestinal absorption of beta-lactam antibiotics in the rat small intestine. J Pharm Pharmacol. 1997;49:796\u2013801.","journal-title":"J Pharm Pharmacol"},{"key":"408_CR2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bcp.2016.03.008","volume":"107","author":"Y Hu","year":"2016","unstructured":"Hu Y, Smith DE. Species differences in the pharmacokinetics of cefadroxil as determined in wildtype and humanized PepT1 mice. Biochem Pharmacol. 2016;107:81\u201390.","journal-title":"Biochem Pharmacol"},{"key":"408_CR3","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1172\/JCI13219","volume":"108","author":"M Buyse","year":"2001","unstructured":"Buyse M, Berlioz F, Guilmeau S, Tsocas A, Voisin T, Peranzi G, et al. PepT1-mediated epithelial transport of dipeptides and cephalexin is enhanced by luminal leptin in the small intestine. J Clin Invest. 2001;108:1483\u201394.","journal-title":"J Clin Invest"},{"key":"408_CR4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11095-008-9703-3","volume":"26","author":"T Hironaka","year":"2009","unstructured":"Hironaka T, Itokawa S, Ogawara K, Higaki K, Kimura T. Quantitative evaluation of PEPT1 contribution to oral absorption of cephalexin in rats. Pharmacol Res. 2009;26:40\u201350.","journal-title":"Pharmacol Res"},{"key":"408_CR5","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1124\/dmd.109.026922","volume":"37","author":"T Ogihara","year":"2009","unstructured":"Ogihara T, Kano T, Wagatsuma T, Wada S, Yabuuchi H, Enomoto S, et al. Oseltamivir (tamiflu) is a substrate of peptide transporter 1. Drug Metab Dispos. 2009;37:1676\u201381.","journal-title":"Drug Metab Dispos"},{"key":"408_CR6","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1007\/s11095-017-2242-z","volume":"34","author":"B Yang","year":"2017","unstructured":"Yang B, Smith DE. In silico absorption analysis of valacyclovir in wildtype and Pept1 knockout mice following oral dose escalation. Pharmacol Res. 2017;34:2349\u201361.","journal-title":"Pharmacol Res"},{"key":"408_CR7","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1124\/dmd.112.049239","volume":"41","author":"B Yang","year":"2013","unstructured":"Yang B, Smith DE. Significance of peptide transporter 1 in the intestinal permeability of valacyclovir in wild-type and PepT1 knockout mice. Drug Metab Dispos. 2013;41:608\u201314.","journal-title":"Drug Metab Dispos"},{"key":"408_CR8","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1124\/dmd.112.044990","volume":"40","author":"A Poirier","year":"2012","unstructured":"Poirier A, Belli S, Funk C, Otteneder MB, Portmann R, Heinig K, et al. Role of the intestinal peptide transporter PEPT1 in oseltamivir absorption: in vitro and in vivo studies. Drug Metab Dispos. 2012;40:1556\u201365.","journal-title":"Drug Metab Dispos"},{"key":"408_CR9","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1124\/dmd.113.052597","volume":"41","author":"B Yang","year":"2013","unstructured":"Yang B, Hu Y, Smith DE. Impact of peptide transporter 1 on the intestinal absorption and pharmacokinetics of valacyclovir after oral dose escalation in wild-type and PepT1 knockout mice. Drug Metab Dispos. 2013;41:1867\u201374.","journal-title":"Drug Metab Dispos"},{"key":"408_CR10","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1023\/A:1007556630189","volume":"17","author":"T Zhu","year":"2000","unstructured":"Zhu T, Chen XZ, Steel A, Hediger MA, Smith DE. Differential recognition of ACE inhibitors in Xenopus laevis oocytes expressing rat PEPT1 and PEPT2. Pharmacol Res. 2000;17:526\u201332.","journal-title":"Pharmacol Res"},{"key":"408_CR11","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1124\/jpet.108.143339","volume":"327","author":"I Knutter","year":"2008","unstructured":"Knutter I, Wollesky C, Kottra G, Hahn MG, Fischer W, Zebisch K, et al. Transport of angiotensin-converting enzyme inhibitors by H+\/peptide transporters revisited. J Pharmacol Exp Ther. 2008;327:432\u201341.","journal-title":"J Pharmacol Exp Ther"},{"key":"408_CR12","doi-asserted-by":"crossref","first-page":"G897","DOI":"10.1152\/ajpgi.00160.2012","volume":"304","author":"D Kolodziejczak","year":"2013","unstructured":"Kolodziejczak D, Spanier B, Pais R, Kraiczy J, Stelzl T, Gedrich K, et al. Mice lacking the intestinal peptide transporter display reduced energy intake and a subtle maldigestion\/malabsorption that protects them from diet-induced obesity. Am J Physiol Gastrointest Liver Physiol. 2013;304:G897\u2013907.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"408_CR13","doi-asserted-by":"crossref","first-page":"E668","DOI":"10.1152\/ajpendo.00437.2013","volume":"306","author":"TT Do","year":"2014","unstructured":"Do TT, Hindlet P, Waligora-Dupriet AJ, Kapel N, Neveux N, Mignon V, et al. Disturbed intestinal nitrogen homeostasis in a mouse model of high-fat diet-induced obesity and glucose intolerance. Am J Physiol Endocrinol Metab. 2014;306:E668\u201380.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"408_CR14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-981-13-7647-4_3","volume":"1141","author":"X Liu","year":"2019","unstructured":"Liu X. SLC family transporters. Adv Exp Med Biol. 2019;1141:101\u2013202.","journal-title":"Adv Exp Med Biol"},{"key":"408_CR15","doi-asserted-by":"crossref","first-page":"G265","DOI":"10.1152\/ajpgi.00055.2010","volume":"299","author":"M Chen","year":"2010","unstructured":"Chen M, Singh A, Xiao F, Dringenberg U, Wang J, Engelhardt R, et al. Gene ablation for PEPT1 in mice abolishes the effects of dipeptides on small intestinal fluid absorption, short-circuit current, and intracellular pH. Am J Physiol Gastrointest Liver Physiol. 2010;299:G265\u201374.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"408_CR16","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03490-8","volume":"9","author":"HJ Dranse","year":"2018","unstructured":"Dranse HJ, Waise TMZ, Hamr SC, Bauer PV, Abraham MA, Rasmussen BA, et al. Physiological and therapeutic regulation of glucose homeostasis by upper small intestinal PepT1-mediated protein sensing. Nat Commun. 2018;9:1118.","journal-title":"Nat Commun"},{"key":"408_CR17","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1007\/s00125-013-3037-3","volume":"56","author":"E Diakogiannaki","year":"2013","unstructured":"Diakogiannaki E, Pais R, Tolhurst G, Parker HE, Horscroft J, Rauscher B, et al. Oligopeptides stimulate glucagon-like peptide-1 secretion in mice through proton-coupled uptake and the calcium-sensing receptor. Diabetologia. 2013;56:2688\u201396.","journal-title":"Diabetologia"},{"key":"408_CR18","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1124\/dmd.118.085803","volume":"47","author":"F Xu","year":"2019","unstructured":"Xu F, Zhu L, Qian C, Zhou J, Geng D, Li P, et al. Impairment of intestinal monocarboxylate transporter 6 function and expression in diabetic rats induced by combination of high-fat diet and low dose of streptozocin: involvement of butyrate-peroxisome proliferator-activated receptor-gamma activation. Drug Metab Dispos. 2019;47:556\u201366.","journal-title":"Drug Metab Dispos"},{"key":"408_CR19","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1139\/Y10-037","volume":"88","author":"AH Der-Boghossian","year":"2010","unstructured":"Der-Boghossian AH, Saad SR, Perreault C, Provost C, Jacques D, Kadi LN, et al. Role of insulin on jejunal PepT1 expression and function regulation in diabetic male and female rats. Can J Physiol Pharmacol. 2010;88:753\u20139.","journal-title":"Can J Physiol Pharm"},{"key":"408_CR20","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1021\/mp049972u","volume":"1","author":"AB Bikhazi","year":"2004","unstructured":"Bikhazi AB, Skoury MM, Zwainy DS, Jurjus AR, Kreydiyyeh SI, Smith DE, et al. Effect of diabetes mellitus and insulin on the regulation of the PepT 1 symporter in rat jejunum. Mol Pharmacol. 2004;1:300\u20138.","journal-title":"Mol Pharmacol"},{"key":"408_CR21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0928-0987(03)00042-3","volume":"19","author":"K Watanabe","year":"2003","unstructured":"Watanabe K, Terada K, Sato J. Intestinal absorption of cephalexin in diabetes mellitus model rats. Eur J Pharm Sci. 2003;19:91\u20138.","journal-title":"Eur J Pharm Sci"},{"key":"408_CR22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.lfs.2018.03.053","volume":"202","author":"MC Losacco","year":"2018","unstructured":"Losacco MC, de Almeida CFT, Hijo AHT, Bargi-Souza P, Gama P, Nunes MT, et al. High-fat diet affects gut nutrients transporters in hypo and hyperthyroid mice by PPAR-alpha independent mechanism. Life Sci. 2018;202:35\u201343.","journal-title":"Life Sci"},{"key":"408_CR23","doi-asserted-by":"crossref","first-page":"e02611","DOI":"10.1016\/j.heliyon.2019.e02611","volume":"5","author":"AH Torelli Hijo","year":"2019","unstructured":"Torelli Hijo AH, Coutinho CP, Alba-Loureiro TC, Moreira Leite JS, Bargi-Souza P, Goulart-Silva F. High fat diet modulates the protein content of nutrient transporters in the small intestine of mice: possible involvement of PKA and PKC activity. Heliyon. 2019;5:e02611.","journal-title":"Heliyon"},{"key":"408_CR24","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1124\/jpet.107.125799","volume":"323","author":"P Hindlet","year":"2007","unstructured":"Hindlet P, Bado A, Farinotti R, Buyse M. Long-term effect of leptin on H+-coupled peptide cotransporter 1 activity and expression in vivo: evidence in leptin-deficient mice. J Pharmacol Exp Ther. 2007;323:192\u2013201.","journal-title":"J Pharmacol Exp Ther"},{"key":"408_CR25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejps.2003.10.002","volume":"21","author":"K Watanabe","year":"2004","unstructured":"Watanabe K, Terada K, Jinriki T, Sato J. Effect of insulin on cephalexin uptake and transepithelial transport in the human intestinal cell line Caco-2. Eur J Pharm Sci. 2004;21:87\u201395.","journal-title":"Eur J Pharm Sci"},{"key":"408_CR26","doi-asserted-by":"crossref","DOI":"10.1186\/s12915-017-0462-7","volume":"15","author":"X Zheng","year":"2017","unstructured":"Zheng X, Huang F, Zhao A, Lei S, Zhang Y, Xie G, et al. Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice. BMC Biol. 2017;15:120.","journal-title":"BMC Biol"},{"key":"408_CR27","doi-asserted-by":"crossref","first-page":"e0202083","DOI":"10.1371\/journal.pone.0202083","volume":"13","author":"K Watanabe","year":"2018","unstructured":"Watanabe K, Igarashi M, Li X, Nakatani A, Miyamoto J, Inaba Y, et al. Dietary soybean protein ameliorates high-fat diet-induced obesity by modifying the gut microbiota-dependent biotransformation of bile acids. PLoS One. 2018;13:e0202083.","journal-title":"PLoS One"},{"key":"408_CR28","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41401-018-0029-3","volume":"40","author":"J Zhao","year":"2019","unstructured":"Zhao J, Zhang QL, Shen JH, Wang K, Liu J. Magnesium lithospermate B improves the gut microbiome and bile acid metabolic profiles in a mouse model of diabetic nephropathy. Acta Pharmacol Sin. 2019;40:507\u201313.","journal-title":"Acta Pharmacol Sin"},{"key":"408_CR29","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/0005-2760(78)90064-4","volume":"529","author":"FO Nervi","year":"1978","unstructured":"Nervi FO, Severin CH, Valdivieso VD. Bile acid pool changes and regulation of cholate synthesis in experimental diabetes. Biochim Biophys Acta. 1978;529:212\u201323.","journal-title":"Biochim Biophys Acta"},{"key":"408_CR30","first-page":"5","volume":"3","author":"AH Ali","year":"2015","unstructured":"Ali AH, Carey EJ, Lindor KD. Recent advances in the development of farnesoid X receptor agonists. Ann Transl Med. 2015;3:5.","journal-title":"Ann Transl Med"},{"key":"408_CR31","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/aps.2016.54","volume":"37","author":"ZY Zhong","year":"2016","unstructured":"Zhong ZY, Sun BB, Shu N, Xie QS, Tang XG, Ling ZL, et al. Ciprofloxacin blocked enterohepatic circulation of diclofenac and alleviated NSAID-induced enteropathy in rats partly by inhibiting intestinal beta-glucuronidase activity. Acta Pharmacol Sin. 2016;37:1002\u201312.","journal-title":"Acta Pharmacol Sin"},{"key":"408_CR32","doi-asserted-by":"crossref","first-page":"8868","DOI":"10.1021\/acs.jafc.9b03173","volume":"67","author":"M Song","year":"2019","unstructured":"Song M, Ye J, Zhang F, Su H, Yang X, He H, et al. Chenodeoxycholic acid (CDCA) protects against the lipopolysaccharide-induced impairment of the intestinal epithelial barrier function via the FXR-MLCK pathway. J Agric Food Chem. 2019;67:8868\u201374.","journal-title":"J Agric Food Chem"},{"key":"408_CR33","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/jnc.13666","volume":"138","author":"Y Li","year":"2016","unstructured":"Li Y, Zhang J, Xu P, Sun B, Zhong Z, Liu C, et al. Acute liver failure impairs function and expression of breast cancer-resistant protein (BCRP) at rat blood-brain barrier partly via ammonia-ROS-ERK1\/2 activation. J Neurochem. 2016;138:282\u201394.","journal-title":"J Neurochem"},{"key":"408_CR34","doi-asserted-by":"crossref","first-page":"C821","DOI":"10.1152\/ajpcell.1999.276.4.C821","volume":"276","author":"M Thamotharan","year":"1999","unstructured":"Thamotharan M, Bawani SZ, Zhou X, Adibi SA. Hormonal regulation of oligopeptide transporter Pept-1 in a human intestinal cell line. Am J Physiol-Cell Ph. 1999;276:C821\u20136.","journal-title":"Am J Physiol-Cell Ph"},{"key":"408_CR35","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s00210-004-0948-z","volume":"370","author":"KT Kivisto","year":"2004","unstructured":"Kivisto KT, Zukunft J, Hofmann U, Niemi M, Rekersbrink S, Schneider S, et al. Characterisation of cerivastatin as a P-glycoprotein substrate: studies in P-glycoprotein-expressing cell monolayers and mdr1a\/b knock-out mice. Naunyn Schmiedebergs Arch Pharmacol. 2004;370:124\u201330.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"408_CR36","volume":"6","author":"C Jiang","year":"2015","unstructured":"Jiang C, Xie C, Lv Y, Li J, Krausz KW, Shi J, et al. Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction. Nat Commun. 2015;6:10166.","journal-title":"Nat Commun"},{"key":"408_CR37","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.1021\/jm0707931","volume":"50","author":"BW Katona","year":"2007","unstructured":"Katona BW, Cummins CL, Ferguson AD, Li T, Schmidt DR, Mangelsdorf DJ, et al. Synthesis, characterization, and receptor interaction profiles of enantiomeric bile acids. J Med Chem. 2007;50:6048\u201358.","journal-title":"J Med Chem"},{"key":"408_CR38","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/0006-2952(84)90660-9","volume":"33","author":"K Rahman","year":"1984","unstructured":"Rahman K, Billington D. Effect of chenodeoxycholate feeding upon the biliary output of plasma membrane enzymes in the rat. Biochem Pharmacol. 1984;33:2231\u20138.","journal-title":"Biochem Pharmacol"},{"key":"408_CR39","doi-asserted-by":"crossref","unstructured":"Bazzari FH, Abdallah DM, El-Abhar HS. Chenodeoxycholic acid ameliorates AlCl3-induced Alzheimer\u2019s disease neurotoxicity and cognitive deterioration via enhanced insulin signaling in rats. Molecules. 2019;24:1992.","DOI":"10.3390\/molecules24101992"},{"key":"408_CR40","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.xphs.2015.11.024","volume":"105","author":"H Arakawa","year":"2016","unstructured":"Arakawa H, Ohmachi T, Ichiba K, Kamioka H, Tomono T, Kanagawa M, et al. Interaction of peptide transporter 1 with D-glucose and L-glutamic acid; possible involvement of taste receptors. J Pharm Sci. 2016;105:339\u201342.","journal-title":"J Pharm Sci"},{"key":"408_CR41","first-page":"1860","volume":"49","author":"T Yang","year":"2018","unstructured":"Yang T, Wang S, Liu P, Xu J, Liu X, Liu L. Influence on compatibility of Glycyrrhiza uralensis and Laminaria japonica on liver and kidney functions and serum indexes in rats. Chin Tradit Herb Drugs. 2018;49:1860\u20135.","journal-title":"Chin Tradit Herb Drugs"},{"key":"408_CR42","doi-asserted-by":"crossref","first-page":"G133","DOI":"10.1152\/ajpgi.00445.2001","volume":"283","author":"A Gangopadhyay","year":"2002","unstructured":"Gangopadhyay A, Thamotharan M, Adibi SA. Regulation of oligopeptide transporter (Pept-1) in experimental diabetes. Am J Physiol Gastrointest Liver Physiol. 2002;283:G133\u20138.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"408_CR43","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1007\/s11095-013-1168-3","volume":"30","author":"MM Posada","year":"2013","unstructured":"Posada MM, Smith DE. In vivo absorption and disposition of cefadroxil after escalating oral doses in wild-type and PepT1 knockout mice. Pharmacol Res. 2013;30:2931\u20139.","journal-title":"Pharmacol Res"},{"key":"408_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2018.06.010","volume":"155","author":"D Epling","year":"2018","unstructured":"Epling D, Hu Y, Smith DE. Evaluating the intestinal and oral absorption of the prodrug valacyclovir in wildtype and huPepT1 transgenic mice. Biochem Pharmacol. 2018;155:1\u20137.","journal-title":"Biochem Pharmacol"},{"key":"408_CR45","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1006\/bbrc.1998.8628","volume":"246","author":"ME Ganapathy","year":"1998","unstructured":"Ganapathy ME, Huang W, Wang H, Ganapathy V, Leibach FH. Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2. Biochem Biophys Res Commun. 1998;246:470\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"408_CR46","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1128\/AM.16.11.1684-1694.1968","volume":"16","author":"P Braun","year":"1968","unstructured":"Braun P, Tillotson JR, Wilcox C, Finland M. Cephalexin and cephaloglycin activity in vitro and absorption and urinary excretion of single oral doses in normal young adults. Appl Microbiol. 1968;16:1684\u201394.","journal-title":"Appl Microbiol"},{"key":"408_CR47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0002-9343(82)90059-6","volume":"73","author":"P de Miranda","year":"1982","unstructured":"de Miranda P, Krasny HC, Page DA, Elion GB. Species differences in the disposition of acyclovir. Am J Med. 1982;73:31\u201335.","journal-title":"Am J Med"},{"key":"408_CR48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41401-019-0283-z","volume":"41","author":"XY Liao","year":"2020","unstructured":"Liao XY, Deng QQ, Han L, Wu ZT, Peng ZL, Xie Y, et al. Leflunomide increased the renal exposure of acyclovir by inhibiting OAT1\/3 and MRP2. Acta Pharmacol Sin. 2020;41:129\u201337.","journal-title":"Acta Pharmacol Sin"},{"key":"408_CR49","doi-asserted-by":"crossref","first-page":"F972","DOI":"10.1152\/ajprenal.00110.2006","volume":"291","author":"G Tramonti","year":"2006","unstructured":"Tramonti G, Xie P, Wallner EI, Danesh FR, Kanwar YS. Expression and functional characteristics of tubular transporters: P-glycoprotein, PEPT1, and PEPT2 in renal mass reduction and diabetes. Am J Physiol Ren Physiol. 2006;291:F972\u201380.","journal-title":"Am J Physiol Ren Physiol"},{"key":"408_CR50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/187231208783478425","volume":"2","author":"MT Nowicki","year":"2008","unstructured":"Nowicki MT, Aleksunes LM, Sawant SP, Dnyanmote AV, Mehendale HM, Manautou JE. Renal and hepatic transporter expression in type 2 diabetic rats. Drug Metab Lett. 2008;2:11\u20137.","journal-title":"Drug Metab Lett"},{"key":"408_CR51","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/MAJ.0b013e3182831740","volume":"347","author":"A Phatchawan","year":"2014","unstructured":"Phatchawan A, Chutima S, Varanuj C, Anusorn L. Decreased renal organic anion transporter 3 expression in type 1 diabetic rats. Am J Med Sci. 2014;347:221\u20137.","journal-title":"Am J Med Sci"},{"key":"408_CR52","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1681\/ASN.2013020126","volume":"24","author":"K Sharma","year":"2013","unstructured":"Sharma K, Karl B, Mathew AV, Gangoiti JA, Wassel CL, Saito R, et al. Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. J Am Soc Nephrol. 2013;24:1901\u201312.","journal-title":"J Am Soc Nephrol"},{"key":"408_CR53","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/17474124.2019.1543023","volume":"13","author":"T Singer-Englar","year":"2019","unstructured":"Singer-Englar T, Barlow G, Mathur R. Obesity, diabetes, and the gut microbiome: an updated review. Expert Rev Gastroenterol Hepatol. 2019;13:3\u201315.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"408_CR54","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/mp0499656","volume":"1","author":"T Maeda","year":"2004","unstructured":"Maeda T, Miyata M, Yotsumoto T, Kobayashi D, Nozawa T, Toyama K, et al. Regulation of drug transporters by the farnesoid X receptor in mice. Mol Pharmacol. 2004;1:281\u20139.","journal-title":"Mol Pharmacol"},{"key":"408_CR55","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1194\/jlr.M700330-JLR200","volume":"48","author":"I Kim","year":"2007","unstructured":"Kim I, Ahn SH, Inagaki T, Choi M, Ito S, Guo GL, et al. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J Lipid Res. 2007;48:2664\u201372.","journal-title":"J Lipid Res"},{"key":"408_CR56","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.toxlet.2018.01.006","volume":"287","author":"X Wang","year":"2018","unstructured":"Wang X, Wang F, Zhang Y, Xiong H, Zhang Y, Zhuang P, et al. Diabetic cognitive dysfunction is associated with increased bile acids in liver and activation of bile acid signaling in intestine. Toxicol Lett. 2018;287:10\u201322.","journal-title":"Toxicol Lett"},{"key":"408_CR57","doi-asserted-by":"crossref","first-page":"25296","DOI":"10.1074\/jbc.M114.577023","volume":"289","author":"A Okamura","year":"2014","unstructured":"Okamura A, Koyanagi S, Dilxiat A, Kusunose N, Chen JJ, Matsunaga N, et al. Bile acid-regulated peroxisome proliferator-activated receptor-alpha (PPARalpha) activity underlies circadian expression of intestinal peptide absorption transporter PepT1\/Slc15a1. J Biol Chem. 2014;289:25296\u2013305.","journal-title":"J Biol Chem"},{"key":"408_CR58","doi-asserted-by":"crossref","first-page":"G851","DOI":"10.1152\/ajpgi.00171.2006","volume":"291","author":"J Shimakura","year":"2006","unstructured":"Shimakura J, Terada T, Saito H, Katsura T, Inui K. Induction of intestinal peptide transporter 1 expression during fasting is mediated via peroxisome proliferator-activated receptor alpha. Am J Physiol Gastrointest Liver Physiol. 2006;291:G851\u20136.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"408_CR59","doi-asserted-by":"crossref","first-page":"G395","DOI":"10.1152\/ajpgi.90317.2008","volume":"295","author":"H Saito","year":"2008","unstructured":"Saito H, Terada T, Shimakura J, Katsura T, Inui K. Regulatory mechanism governing the diurnal rhythm of intestinal H+\/peptide cotransporter 1 (PEPT1). Am J Physiol Gastrointest Liver Physiol. 2008;295:G395\u2013402.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"408_CR60","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1248\/bpb.30.2185","volume":"30","author":"T Hirai","year":"2007","unstructured":"Hirai T, Fukui Y, Motojima K. PPARalpha agonists positively and negatively regulate the expression of several nutrient\/drug transporters in mouse small intestine. Biol Pharm Bull. 2007;30:2185\u201390.","journal-title":"Biol Pharm Bull"},{"key":"408_CR61","first-page":"493","volume":"27","author":"C Adithan","year":"1989","unstructured":"Adithan C, Sriram G, Swaminathan RP, Shashindran CH, Bapna JS, Krishnan M, et al. Differential effect of type I and type II diabetes mellitus on serum ampicillin levels. Int J Clin Pharmacol Ther Toxicol. 1989;27:493\u20138.","journal-title":"Int J Clin Pharmacol Ther Toxicol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41401-020-0408-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-020-0408-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-020-0408-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:03:20Z","timestamp":1684616600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-0408-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,27]]},"references-count":61,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["408"],"URL":"https:\/\/doi.org\/10.1038\/s41401-020-0408-4","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,27]]},"assertion":[{"value":"14 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}